Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
Top Cited Papers
Open Access
- 1 November 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
Objective To report the induction of anti–Ma2 antibody–associated paraneoplastic neurologic syndrome (Ma2-PNS) in 6 patients after treatment with immune checkpoint inhibitors (ICIs). We also analyzed (1) patient clinical features compared with a cohort of 44 patients who developed Ma2-PNS without receiving ICI treatment and (2) the frequency of neuronal antibody detection before and after ICI implementation. Methods Retrospective nationwide study of all patients with Ma2-PNS developed during ICI treatment between 2017 and 2018. Results Our series of patients included 5 men and 1 woman (median age, 63 years). The patients were receiving nivolumab (n = 3), pembrolizumab (n = 2), or a combination of nivolumab and ipilimumab (n = 1) for treatment of neoplasms that included lung (n = 4) and kidney (n = 1) cancers and pleural mesothelioma (n = 1). Clinical syndromes comprised a combination of limbic encephalitis and diencephalitis (n = 3), isolated limbic encephalitis (n = 2), and a syndrome characterized by ophthalmoplegia and head drop (n = 1). No significant clinical difference was observed between our 6 patients and the overall cohort of Ma2-PNS cases. Post-ICI Ma2-PNS accounted for 35% of the total 17 Ma2-PNS diagnosed in our center over the 2017–2018 biennium. Eight cases had been detected in the preceding biennium 2015–2016, corresponding to a 112% increase of Ma2-PNS frequency since the implementation of ICIs in France. Despite ICI withdrawal and immunotherapy, 4/6 patients died, and the remaining 2 showed a moderate to severe disability. Conclusions We show a clear association between ICI use and increased diagnosis of Ma2-PNS. Physicians need to be aware that ICIs can trigger Ma2-PNS because clinical presentation can be challenging.Keywords
This publication has 33 references indexed in Scilit:
- Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesotheliomaJournal of the Neurological Sciences, 2015
- Neuropsychiatric Manifestations of Thyroid DiseaseEndocrinology and Metabolism Clinics of North America, 2013
- Hypothalamic Immunopathology in Anti-Ma–Associated Diencephalitis With Narcolepsy-CataplexyJAMA Neurology, 2013
- Narcolepsy, REM Sleep Behavior Disorder, and Supranuclear Gaze Palsy Associated With Ma1 and Ma2 Antibodies and Tonsillar CarcinomaArchives of Neurology, 2011
- Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous casesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Paraneoplastic neurological syndromesOrphanet Journal of Rare Diseases, 2007
- Recommended diagnostic criteria for paraneoplastic neurological syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Clinical analysis of anti-Ma2-associated encephalitisBrain, 2004
- Molecular and clinical diversity in paraneoplastic immunity to Ma proteinsAnnals of Neurology, 2001
- A Serologic Marker of Paraneoplastic Limbic and Brain-Stem Encephalitis in Patients with Testicular CancerThe New England Journal of Medicine, 1999